Literature DB >> 24611576

Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy.

N Witting1, A Mensah, L Køber, H Bundgaard, H Petri, M Duno, D Milea, J Vissing.   

Abstract

OBJECTIVES: To assess skeletal muscle weakness and progression as well as the cardiopulmonary involvement in oculopharyngeal muscular dystrophy (OPMD).
MATERIALS AND METHODS: Cross-sectional study including symptomatic patients with genetically confirmed OPMD. Patients were assessed by medical history, ptosis, ophthalmoplegia, facial and limb strength, and swallowing capability. Cardiopulmonary function was evaluated using forced expiratory capacity in 1 s (FEV1), electrocardiogram (ECG), Holter monitoring, and echocardiography.
RESULTS: We included 13 symptomatic patients (six males, mean age; 64 years (41-80) from 8 families. Ptosis was the first symptom in 8/13 patients followed by limb weakness in the remaining 5 patients Dysphagia was never the presenting symptom. At the time of examination, all affected patients had ptosis or had previously been operated for ptosis, while ophthalmoplegia was found in 9 patients. Dysphagia, tested by cold-water swallowing test, was abnormal in 9 patients (17-116 s, ref <8 s). Six patients could not climb stairs of whom two were wheelchair bound and one used a rollator. Six patients had reduced FEV1 (range 23%-59%). No cardiac involvement was identified.
CONCLUSIONS: Limiting limb weakness is common in OPMD and can even be the presenting symptom of the disease. In contrast, dysphagia was not the initial symptom in any of our patients, although it was obligatory for diagnosing OPMD before genetic testing became available. Mild respiratory dysfunction, but no cardiac involvement, was detected.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  muscle disorders; neurodegenerative disorders; neurogenetics; neuroophthalmology

Mesh:

Year:  2014        PMID: 24611576     DOI: 10.1111/ane.12244

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

Review 1.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

2.  Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.

Authors:  Sarah Youssof; Ronald Schrader; David Bear; Leslie Morrison
Journal:  Neuromuscul Disord       Date:  2014-11-20       Impact factor: 4.296

Review 3.  Oculopharyngeal muscular dystrophy as a paradigm for muscle aging.

Authors:  Yotam Raz; Vered Raz
Journal:  Front Aging Neurosci       Date:  2014-11-10       Impact factor: 5.750

4.  Physiology of respiratory disturbances in muscular dystrophies.

Authors:  Antonella Lo Mauro; Andrea Aliverti
Journal:  Breathe (Sheff)       Date:  2016-12

5.  PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.

Authors:  Pascale Richard; Capucine Trollet; Teresa Gidaro; Laurence Demay; Guy Brochier; Edoardo Malfatti; Fernando Ms Tom; Michel Fardeau; Pascal Lafor; Norma Romero; Marie-Laure Martin-N; Guilhem Sol; Xavier Ferrer-Monasterio; Jean Lacau Saint-Guily; Bruno Eymard
Journal:  J Neuromuscul Dis       Date:  2015-06-04

6.  Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature.

Authors:  Omid Aryani; Mohammadreza Akbari; Masoud Aghsaei-Fard; Arash Mirmohammad-Sadeghi; Samira Yadegari
Journal:  Iran J Neurol       Date:  2017-04-04

Review 7.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.